Study Stopped
The study was terminated by NIH on March 21, 2025 due to new guidelines.
Electronic SBI(RT) for MSM in Argentina
Integration of Electronic SBI(RT) Into an HIV Testing Program to Reduce Substance Use and HIV Risk Behavior Among MSM in Argentina
1 other identifier
interventional
196
1 country
1
Brief Summary
Men who have sex with men (MSM) are disproportionally affected by HIV and substance abuse in the U.S., Europe, and Latin America. However, as in the general population, identifying and engaging MSM with problematic substance use (PSU) into treatment is a significant challenge, which results in the great majority of MSM with PSU never receiving treatment. The proposed study seeks to develop and pilot an electronic-Screening, Brief Intervention, Referral to Treatment (e-SBI-RT)program tailored for MSM awaiting their HIV test at Nexo Asociacion Civil, our community partners in Buenos Aires. The tablet-based e-SBI will integrate substance use and sexual risk behavior screeners and individually tailored Motivational Interviewing (MI) as the BI. We will also adapt and pilot the implementation of the Young Men's Health Project (from YMHP to MHP) a four-session MI-based intervention that effectively reduced substance use and condomless anal intercourse among substance using MSM. The Specific Aims of this R34 study are to: 1) develop the e-SBI intervention for MSM in an HIV testing context to reduce substance use and HIV risk behavior (Primary); 2) assess the feasibility and acceptability of integrating e-SBI into the HIV testing process at Nexo; and 3) assess the feasibility and acceptability of implementing adapted YMHP at Nexo. In Stage 1 (Development) we will develop e-SBI, adapt YMHP into MHP, train MHP counselors, and pilot e-SBI with 50 MSM coming to Nexo for HIV testing. In Stage 2 (RCT Pilot), we will randomize 200 MSM coming to Nexo for HIV testing at a 3:1 ratio (eSBI: Screening Assessments Only-SA) to assess the feasibility and acceptability of e-SBI among MSM coming to Nexo for HIV testing and establish and pilot the RCT process for a future trial. As a secondary aim, we will assess uptake, acceptability, and feasibility of delivering MHP to participants with low or moderate risk substance use and subsequent referrals to substance abuse treatment among participants with high-risk substance use or dependence. Lastly, we will explore preliminary findings on substance use and sexual risk reduction outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 6, 2022
CompletedFirst Posted
Study publicly available on registry
September 16, 2022
CompletedStudy Start
First participant enrolled
November 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2025
CompletedJune 27, 2025
June 1, 2025
2.4 years
September 6, 2022
June 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Recruitment Rate: Percent of MSM testing clients at Nexo who accept entry into the study
Will tabulate the percentage of MSM testing clients at Nexo who accept entry into the study vs those who refuse entry
8 months
Retention Rate: percent of participants who complete e-SBI
Will calculate the percent of participants who fully complete the e-SBI vs participants who do not complete the intervention
6 months
Mean overall acceptability rating of e-SBI from the TFA questionnaire
Will use the last question on the TFA questionnaire "Overall, how acceptable is the e-SBI to you?" to calculate mean overall acceptability and percent of participants who rate acceptability at 4 or higher.
6 months
Secondary Outcomes (4)
the percent of MSM with moderate or high-risk substance use who enter MHP from either RCT condition
6 months
the percent of MHP participants who complete all four sessions
6 months
Mean overall acceptability rating of MHP from the TFA questionnaire
6 months
percentage of sessions conducted by each MHP counselor that meet criteria for MI proficiency
6 months
Other Outcomes (3)
Occasions of drug use during the past month
30 days
Occasions of heavy alcohol consumption (5+ drinks) during the past month
30 days
Occasions of anal intercourse during the past month with a partner who is HIV positive or of unknown serostatus .
30 days
Study Arms (2)
e-SBI
EXPERIMENTALElectronic Screening and Brief Intervention for substance use and HIV risk reduction
Assessment Only
ACTIVE COMPARATORThese individuals complete only the screening instruments, no brief intervention
Interventions
e-SBIs is an evidence based approach to engage non-treatment-seeking individuals who use substances to reduce use or enter treatment. It consists of completing screening instruments related to substance use and sexual risk behavior and receiving a tablet-based, Motivational Interviewing intervention to help individuals build motivation to reduce their use and plans to achieve their substance use and HIV risk reduction goals.
This intervention will be offered to participants with moderate or greater severity substance use. This is a 4-session Motivational interviewing based intervention that has shown efficacy in prior studies. We are providing this as a possible referral program for study participants (either arm) who are interested in receiving substance abuse intervention.
Eligibility Criteria
You may qualify if:
- Participants in Stage 1 Focus Groups (FGs) and in-depth interviews (IDIs):
- Man who has had sex with men in the past 6 months;
- years of age or older;
- Recently sought an HIV test at Nexo;
- Reports using drugs least once per month in the past 6 months and/or score 4 or greater on the AUDIT C, suggesting moderate risk alcohol use.
- Participants in Stage 1 e-SBI pilot and the Stage 2 RCT:
- Man who has had sex with men in the past 6 months
- years of age or older;
- Currently seeking an HIV test at Nexo
- \. Score of moderate or high risk drug or alcohol use based on the ASSIST and AUDIT, respectively
You may not qualify if:
- be in need of acute detoxification, as demonstrated by physical withdrawal symptoms or a history of withdrawal, such as previous delirium tremens or seizures
- reported regular use of opioids
- enrolled in concurrent drug- or alcohol-related treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Florida State Universitylead
- Nexo Asociacion Civilcollaborator
Study Sites (1)
Nexo Asociacion Civil
Buenos Aires, C1022AAD, Argentina
Related Publications (1)
Balan IC, Marone RO, Barreda V, Naar S, Wang Y. Integration of an Electronic Screening, Brief Intervention, and Referral to Treatment Program Into an HIV Testing Program to Reduce Substance Use and HIV Risk Behavior Among Men Who Have Sex With Men: Protocol for Intervention Development and a Pilot Randomized Controlled Trial. JMIR Res Protoc. 2024 Mar 14;13:e56683. doi: 10.2196/56683.
PMID: 38483463DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ivan C Balan
Florida State University, College of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Professor
Study Record Dates
First Submitted
September 6, 2022
First Posted
September 16, 2022
Study Start
November 1, 2022
Primary Completion
March 15, 2025
Study Completion
March 15, 2025
Last Updated
June 27, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Starting 6 months after publication of main study findings.
- Access Criteria
- We will collaborate with and make our data available to other researchers for additional/secondary analyses. Dr. Balán and the research team will develop a process to review and approve data release based on concept sheets submitted by interested investigators and whether the data request is for new lines of analysis. Formal data sharing agreements will be developed to guide and encourage further data mining of the proposed datasets for various purposes
We will compile structured de-identified datasets and can make them available for additional/secondary data analyses. The research team will follow the "standards for privacy of individually identifiable health information." Participants' records and results will not be identified. No contact information will be included in any archived datasets. To preclude indirect identification, certain data elements such as date of birth will be transformed; date of birth will be used to provide a categorical age variable.